Yet, patients without SARS-CoV-2 tended to recover eGFR and had a positive trend in EGF and the tubular secretory clearance compared to patients with COVID-19, suggesting a slower pattern of kidney recovery in COVID-19 which is consistent with clinical observation. The gene discussed is EGF; the disease is COVID-19.